Patterns of genotype distribution in multiple human papillomavirus infections

Clinical Microbiology and Infection

Volumn 14, Issue 1, 2008, Pages 60-65

  Oliveira, L H S ^a   Rosa, M L G ^a   Cavalcanti, S M B ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Cervical cancer; Cross sectional study; Genotypes; Human papillomavirus; Multiple infections; Risk factors

Indexed keywords

ABORTION; ADOLESCENT; ADULT; AGED; ARTICLE; CLADISTICS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE CLUSTER; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHYLOGENY; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; SUPERINFECTION; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE; UTERINE CERVIX DYSPLASIA; VERRUCA VULGARIS; VIRAL GENETICS; VIRUS CARCINOGENESIS; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 36849066847     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01887.x     Document Type: Article

References (24)

1. Johnson T, Bryder K, Corbert S, Fomsgaard A. Routine genotyping of human papillomavirus samples in Denmark. APMIS 2003; 111: 398-404.
2. Bosch FX, Lorincz A, Munoz N et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.
3. Chan S, Delius H, Halpern A, Bernard HU. Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny, and taxonomy. J Virol 1995; 69: 3074-3083.
4. Palefsky JM, Minkoff H, Kalish LA et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999; 91: 226-236.
5. Roden RB, Hubbert NL, Kirnbauer R et al. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J Virol 1996; 70: 3298-3301.
6. Trottier H, Mahmud S, Costa MC et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2006; 15: 1274-1280.
7. Levi JE, Fernandes S, Tateno AF et al. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Oncol 2004; 92: 225-231.
8. Mendez F, Munoz N, Posso H et al. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 2005; 192: 1158-1165.
9. Pereira CR, Rosa ML, Vasconcelos GA et al. Human papillomavirus prevalence and predictors for cervical cancer among high risk women from Rio de Janeiro, Brazil. Int J Gynecol Cancer 2007; 17: 651-660.
10. Manos MM, Ting Y, Wright DK et al. Use of polymerase chain reaction amplification for detection of genital papillomavirus. Cancer Cells 1989; 7: 209-214.
11. Gall K, Pavicic D, Pavelic J, Audy-Jurkovic S, Pavelic K. PCR amplification of DNA from stained cytological smears. J Clin Pathol 1993; 46: 378-379.
12. Young LS, Bevan IS, Johnson MA et al. The polymerase chain reaction: A new epidemiological tool for investigating cervical human papillomavirus infection. BMJ 1989; 298: 14-18.
13. Deluca GD, Lucero RH, Civetta MTM et al. Human papillomavirus genotypes in women with cervical abnormalities from an area with high incidence of cervical cancer. Rev Inst Med Trop S Paulo 2004; 46: 9-12.
14. Stevens MP, Tabrizi SN, Quinn MA, Garland SM. Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia. Int J Gynecol Cancer 2006; 16: 1017-1024.
15. Perrons C, Jelley R, Kleter B et al. Detection of persistent high risk human papillomavirus infections with hybrid captureII and SPF10/LiPA. J Clin Virol 2005; 32: 278-285.
16. Thomas KK, Hughes JP, Kuypers JM et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 2000; 182: 1097-1102.
17. Franco EL, Villa LL, Ruiz A, Costa MC. Transmission of cervical human papillomavirus infection by sexual activity: Differences between low and high oncogenic risk types. J Infect Dis 1995; 172: 756-763.
18. Rousseau MC, Franco EL, Villa LL et al. A cumulative case-control study of risk factor profiles for oncogenic and non-oncogenic cervical human papillomavirus infections. Cancer Epidemiol Biomarkers Prev 2000; 9: 469-476.
19. Chaturvedi AK, Myers L, Hammons AF et al. Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol Biomarkers Prev 2005; 14: 2439-2445.
20. Levi JE, Kleter B, Quint WG et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002; 40: 3341-3345.
21. Park TC, Kim CJ, Koh YM et al. Human papillomavirus genotyping by the DNA chip in the cervical neoplasia. DNA Cell Biol 2004; 23: 119-125.
22. Cuschieri KS, Cubie HA, Whitley MV et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004; 57: 68-72.
23. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.
24. Fife KH, Cramer HM, Schroeder JM, Brown DR. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 2001; 64: 550-559.